🇺🇸 FDA
Patent

US 7776564

Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use

granted A61PA61P11/00A61P17/00

Quick answer

US patent 7776564 (Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use) held by Five Prime Therapeutics, Inc. expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Five Prime Therapeutics, Inc.
Grant date
Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P11/00, A61P17/00, A61P3/10, A61P31/00